Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.
Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.
We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.
In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months. Request Insights
The vibrator mesh nebulizer is estimated to grow with a moderate CAGR during the forecast period, i.e., 2021-2029. Vibrator mesh nebulizer is a type of nebulizer used to administer inhaled antibiotics, corticosteroids, and other drugs. Extensive research associated with chronic respiratory conditions in western countries, along with the growing investment in the development of advanced mesh nebulizers use lower-frequency waves, are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and the rising prevalence of respiratory disorders such as CPOD, asthma and cystic fibrosis, and obstructive lung disorders among individuals. According to the data collected from World Health Organization, more than 90% of COPD deaths are recorded in low-income and middle-income countries. This indicates that shows 3 million people die each year from COPD.
The market is segmented based on type into active mesh nebulizers, passive mesh nebulizers, out of which, the active mesh nebulizers segment is anticipated to grab the largest share by the end of 2021 on account of the technological advancements, portability and better efficiency of active mesh nebulizers than passive. Furthermore, active mesh nebulizers use a piezo feature that contracts and expands in response to an electric current and vibrates a precisely drilled mesh in contact with the drug in order to produce an aerosol, which is also projected to contribute to the growth of the segment during the forecast period.CLICK TO DOWNLOAD SAMPLE
On the basis of application, the clinics segment in the global vibrator mesh nebulizer market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the rising number of private respiratory clinics and the rise in the adoption of advanced technologies for respiratory care in clinics.
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa region. The market in North America is predicted to grow at the highest CAGR over the forecast period owing to the well-developed healthcare infrastructure and technological advancement in the region. Along with this, adequate reimbursement policies for these devices also boost the market growth in the region. Furthermore, in 2020, the market in the Asia Pacific is expected to be the fastest-growing region, owing to the rising awareness regarding the application of vibrator mesh nebulizers and increasing geriatric population coupled with high cases of chronic respiratory disorder in the main factor for the growth of vibrator mesh nebulizer market.
According to the Centers for Disease Control and Prevention (CDC), every 1 in 13 suffering from asthma in the country. The high prevalence of COPD and asthma in children and adults propel the demand for vibrator mesh nebulizer in the U.S.
The global vibrator mesh nebulizer market is further classified on the basis of region as follows:
Our in-depth analysis of the global vibrator mesh nebulizer market includes the following segments:
FREQUENTLY ASKED QUESTIONS
Rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis are the key factors driving market growth.
The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.
Presence of substitutes for treatment are estimated to hamper market growth.
The market in Asia Pacific region will provide ample growth opportunities owing to the increasing awareness about vibrator mesh nebulizer and rising geriatric population in the region.
The major players dominating the vibrating mesh nebulizer market are Pfizer Inc., Bayer AG, Astellas Pharma US, Inc., and Merck Sharp & Dohme Corp. among others.
The company profiles are selected on the basis of revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by type, portability, distribution channels, end-users and region.
With respect to end-user, the clinics segment is anticipated to hold the largest market share owing to the rising number of private respiratory care clinics.
Related Reports
Disclaimer | Privacy Policy | Terms & Conditions
Copyright © 2020 Research Nester. All Rights Reserved
